Post-ACL Reconstruction Pain Management at Day 19: Medication Ranking
At 19 days post-ACL reconstruction, celecoxib should be your first choice, followed by mefenamic acid as second-line, while Norgesic (orphenadrine compound) should be avoided entirely for this indication.
Recommended Ranking
1. Celecoxib (First Choice)
Celecoxib 200 mg twice daily is the optimal choice for post-ACL pain at day 19 based on multiple converging lines of evidence 1, 2, 3.
Why celecoxib wins:
Procedure-specific evidence for orthopedic surgery: Guidelines for total knee arthroplasty (transferable to ACL reconstruction) give COX-2 selective inhibitors a Grade A recommendation for postoperative analgesia, specifically noting they reduce pain scores and supplemental analgesic requirements 1
Direct ACL reconstruction data: A randomized trial of 200 patients undergoing ACL reconstruction demonstrated that celecoxib 400 mg preoperatively followed by 200 mg twice daily postoperatively resulted in lower pain scores both at rest and with movement, reduced opioid consumption at all time intervals, and earlier hospital discharge 2
Superior safety profile: Celecoxib has significantly lower gastrointestinal toxicity compared to non-selective NSAIDs while maintaining equivalent cardiovascular safety 4, 5. The PRECISION trial demonstrated non-inferiority to naproxen and ibuprofen for cardiovascular events 4
No bone healing concerns: Limited evidence shows COX-2 inhibitors have no detrimental effects on bone healing, addressing a theoretical concern with NSAIDs in orthopedic surgery 1
Multimodal analgesia component: Works synergistically when combined with acetaminophen, which you should also be taking 6, 7
Dosing at day 19: Celecoxib 200 mg twice daily, combined with acetaminophen 1000 mg every 6 hours 2, 7
2. Mefenamic Acid (Second Choice)
Mefenamic acid 500 mg three times daily can serve as an alternative if celecoxib is unavailable or contraindicated, though evidence is weaker.
Why it's second-line:
Limited orthopedic data: While mefenamic acid has demonstrated efficacy for acute postoperative pain with an NNT of 4.0 for 50% pain relief 8, the evidence comes primarily from dental and episiotomy studies, not orthopedic procedures
Non-selective NSAID risks: As a non-selective NSAID, mefenamic acid carries higher gastrointestinal risk than celecoxib 9, 10. Guidelines consistently note that non-selective NSAIDs should be used with caution regarding bleeding complications and gastroduodenal ulcer history 1
Shorter duration of action: Requires three-times-daily dosing versus twice-daily for celecoxib, potentially affecting compliance 11, 8
Less robust evidence base: Cochrane review noted "limited data" for mefenamic acid in postoperative pain, with only 4 studies meeting inclusion criteria 8
If using mefenamic acid: 500 mg three times daily with food, combined with acetaminophen for multimodal analgesia 8
3. Norgesic (Not Recommended)
Norgesic (orphenadrine/aspirin/caffeine combination) should not be used for post-ACL reconstruction pain at day 19.
Why to avoid:
Zero evidence base: No guideline or research evidence supports Norgesic for postoperative orthopedic pain management. It does not appear in any ACL reconstruction, knee arthroplasty, or orthopedic surgery pain management guideline 12, 1, 12, 1, 13, 14
Inappropriate mechanism: Orphenadrine is a muscle relaxant with anticholinergic properties, not addressing the inflammatory component of post-surgical pain that predominates at day 19
Aspirin component problematic: The aspirin in Norgesic increases bleeding risk, which is particularly concerning in the post-surgical period. Guidelines specifically recommend against non-selective NSAIDs when COX-2 inhibitors are available due to superior GI safety 9, 1
Sedation concerns: Orphenadrine causes significant sedation and anticholinergic side effects (dry mouth, urinary retention, confusion), which impair rehabilitation—a critical component of ACL recovery 13, 14
Clinical Implementation Algorithm
At day 19 post-ACL reconstruction, follow this approach:
Start with celecoxib 200 mg twice daily + acetaminophen 1000 mg every 6 hours as baseline multimodal analgesia 2, 7
Screen for contraindications before prescribing celecoxib:
- Active cardiovascular disease (recent MI, unstable angina)
- Severe renal impairment (CrCl <30 mL/min)
- Active peptic ulcer disease
- Aspirin-sensitive asthma
- Third trimester pregnancy 4
If celecoxib is contraindicated, switch to mefenamic acid 500 mg three times daily + acetaminophen 8
For breakthrough pain, use short-acting opioids (oxycodone 5 mg) sparingly rather than increasing NSAID doses 7, 15, 16
Avoid Norgesic entirely—it has no role in evidence-based post-ACL pain management
Important Caveats
Duration of NSAID therapy: At day 19, you're in the subacute phase. Most guidelines support NSAID use for 2-4 weeks postoperatively 12, 1, 12. Consider tapering after 3-4 weeks as pain improves with rehabilitation.
Rehabilitation is paramount: Pain medication facilitates, but does not replace, structured physical therapy. By day 19, you should be progressing through range of motion exercises, quadriceps strengthening, and early weight-bearing activities 13, 14. Adequate analgesia enables this rehabilitation.
Multimodal approach is non-negotiable: Never use NSAIDs alone. The combination of celecoxib + acetaminophen reduces opioid consumption by 70-90% compared to opioids alone 2, 7, 17. This is the standard of care.
Individual risk assessment matters: While celecoxib has superior GI safety overall, patients with multiple cardiovascular risk factors require careful consideration. The PRECISION trial showed non-inferiority, but real-world evidence suggests caution in high-risk populations 4, 5.
Opioid-sparing is the goal: Studies show that multimodal analgesia with celecoxib can reduce or eliminate opioid use after ACL reconstruction 7, 16, 17. At day 19, you should be minimizing or discontinuing opioids entirely if pain is controlled with NSAIDs and acetaminophen.